沙利文与数因智科联合发布《2026年siRNA在消费级领域应用场景白皮书》
Frost & Sullivan and DigitalGene.AI Jointly Releases the " White Paper on Applications of siRNA in the Consumer Sector 2026"
长期以来，传统功效原料多作用于蛋白层面，较难从源头精准干预肌肤问题。siRNA能够靶向调控基因表达，凭借较高的特异性，为美白、抗衰、抗敏、控油及防脱等功效产品提供新的技术路径。此次白皮书重点围绕siRNA消费级市场的发展趋势与产业机会、小核酸技术在化妆品领域的核心消费场景、原料研发与递送商业化过程中的关键挑战及监管趋势，以及基因科技与美妆产业融合方向展开。
作为AI数据驱动的创新科技企业，数因智科长期深耕“AI+siRNA”底层技术，依托AI靶点筛选与分子设计、高通量实验验证及皮肤递送等能力，打通靶点发现、分子设计、功效验证及应用转化全链条，并围绕创新小核酸原料研发和功效护肤产品开发持续推进产业合作。其打造的科白因、科溯因、科御因创新原料已实现消费级应用落地，推动siRNA技术由实验室研究加快迈向消费市场。
展望未来，随着递送效率、功效稳定性及规模化生产能力持续提升，siRNA有望在精准功效护肤及个性化产品开发中释放更大价值。
For years, conventional active ingredients have primarily acted at the protein level, making it difficult to address skin concerns precisely at their source. By selectively regulating gene expression, siRNA offers a highly specific technological pathway for efficacy claims such as brightening, anti-aging, soothing, sebum control and hair-loss prevention. The white paper focuses on market trends and commercial opportunities for siRNA in the consumer sector, key applications of small nucleic acid technologies in cosmetics, major challenges and regulatory developments in ingredient development and delivery commercialization, and the convergence of gene technology and the beauty industry.
As an AI- and data-driven innovation company, DigitalGene.AI has developed deep expertise in foundational “AI + siRNA” technologies. Its capabilities in AI-enabled target screening and molecular design, high-throughput experimental validation and skin delivery span the full value chain—from target discovery and molecular design to efficacy validation and application development. The company also continues to advance industry partnerships in innovative small nucleic acid ingredients and efficacy-driven skincare products. Its proprietary ingredients, SciClarity, SciVital and SciDefend, have already been commercialized in consumer applications, accelerating the transition of siRNA technology from laboratory research to the consumer market.
Looking ahead, continued improvements in delivery efficiency, efficacy stability and scalable manufacturing are expected to unlock greater value for siRNA in precision skincare and personalized product development.
点击以下链接，查看节选版 报告：
如果您对中国小干扰核酸消费类应用市场有进一步的研究需求，请联系我们：
沙利文 刘女士
E-mail: stella.liu@frostchina.com
